Baumgardner CBO Study Cited in New York Times

In a new commentary by Aaron Carroll appearing in the New York Times, the author examines preventative care and conventional wisdom that the practice saves money. Surprisingly, Carroll makes some strong arguments that the costs for preventative care are actually significant, but that the practice can improve quality of life at a very reasonable price.

Central to Carroll’s argument is a study recently published in the New England Journal of Medicine in which researchers modeled how a policy to reduce smoking through higher cigarette taxes might affect federal spending. The study, authored by the CBO, was led by PHE Senior Research Economist James Baumgardner during his tenure with the agency.

To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.